DeepMed Research

Nanfang Hospital Southern Medical University

🇨🇳China

Country: 🇨🇳China

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Idarubicin Overcomes MDR1 Induced Chemoresistance With Higher Induction Remission Rate and Quality Than Daunorubicin in Acute Myeloid Leukemia Patients

Conditions: Acute Myeloid Leukemia

Interventions: Drug: Idarubicin

First Posted Date: 2013-06-28

Last Posted Date: 2015-04-21

Lead Sponsor: Nanfang Hospital, Southern Medical University

Target Recruit Count: 94

Registration Number: NCT01889407

Locations: 🇨🇳
Bing Xu, GuangZhou, Guangdong, China

A Control Study to Evaluate The Efficacy And Safety of Ozone-therapy in Chronic Hepatitis B

Phase 4

Completed

Conditions: Chronic Hepatitis B

Interventions: Device: medical ozone therapy with humares
Drug: conventional interferon-α

First Posted Date: 2013-06-26

Last Posted Date: 2013-06-26

Lead Sponsor: Nanfang Hospital, Southern Medical University

Target Recruit Count: 439

Registration Number: NCT01887275

Locations: 🇨🇳
Nanfang Hospital, GuangZhou, Guangdong, China

A Multicentre Trial of Nerve-Spring Radical Hysterectomy vs. Radical Hysterectomy for Cervical Cancer

Not Applicable

Conditions: Cervical Cancer

Interventions: Procedure: Nerve-spring radical hysterectomy
Procedure: radical hysterectomy

First Posted Date: 2013-06-26

Last Posted Date: 2013-07-22

Lead Sponsor: Nanfang Hospital, Southern Medical University

Target Recruit Count: 240

Registration Number: NCT01886508

Locations: 🇨🇳
Southern Medical University, China, Guangzhou, Guangdong, China

TKI Therapy Based on Molecular Monitoring in Allogeneic-HSCT Recipients With Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia

Phase 2

Conditions: Philadelphia Chromosome Positive Acute Lymphocytic Leukemia
Stem Cell Transplantation
Minimal Residual Disease

Interventions: Drug: TKIs

First Posted Date: 2013-06-21

Last Posted Date: 2017-11-08

Lead Sponsor: Nanfang Hospital, Southern Medical University

Target Recruit Count: 80

Registration Number: NCT01883219

Locations: 🇨🇳
Department of Hematology,Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China

ATG in Haploidentical HSCT for Acute Graft-versus-host Disease Prophylaxis

Phase 4

Completed

Conditions: Hematopoietic Stem Cell Transplantation
Antithymocyte Globulin
Viral Infection

Interventions: Drug: ATG

First Posted Date: 2013-06-21

Last Posted Date: 2018-04-24

Lead Sponsor: Nanfang Hospital, Southern Medical University

Target Recruit Count: 412

Registration Number: NCT01883180

Locations: 🇨🇳
Department of Hematology,Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China

HD-Idarubicin/Etoposide Intensified Conditioning Regimen Allo-HSCT for Adult ALL

Phase 4

Conditions: Acute Lymphoblastic Leukemia

Interventions: Radiation: TBI
Drug: IDA
Drug: CTX
Drug: VP-16

First Posted Date: 2013-06-10

Last Posted Date: 2015-10-09

Lead Sponsor: Nanfang Hospital, Southern Medical University

Target Recruit Count: 100

Registration Number: NCT01873807

Locations: 🇨🇳
Department of Hematology, Union Hospital of Fujian Medical University, Fuzhou, Fujian, China
🇨🇳
Guangzhou General Hospital of Guangzhou Military Command, Guangzhou, Guangdong, China
🇨🇳
Guangdong General Hospital, Guangzhou, Guangdong, China

and more 10 locations

3E Extension Study

Phase 4

Conditions: Chronic Hepatitis B

Interventions: Drug: oral entecavir 0.5mg daily and adefovir 10mg daily for 144 weeks

First Posted Date: 2013-04-18

Last Posted Date: 2014-06-19

Lead Sponsor: Nanfang Hospital, Southern Medical University

Target Recruit Count: 600

Registration Number: NCT01834508

Locations: 🇨🇳
Beijing Ditan Hospita, Beijing, Beijing, China
🇨🇳
First Hospital .Jilin Unniversity, Changchun, Jilin, China
🇨🇳
ShengJing Hospital of China Medical University, Shengyang, Liaoning, China

and more 25 locations

Efficacy Optimizing Extension Study of Chronic Hepatitis B Patients With Inadequate Response to NUC Therapy

Phase 4

Conditions: Chronic Hepatitis B
Inadequate Response
Nucleos(t)Ide Analogues Treatment

Interventions: Drug: Entecavir, Adefovir

First Posted Date: 2013-04-11

Last Posted Date: 2014-06-19

Lead Sponsor: Nanfang Hospital, Southern Medical University

Target Recruit Count: 360

Registration Number: NCT01829685

Locations: 🇨🇳
Beijing Ditan Hospital, Beijing, Beijing, China
🇨🇳
Beijing Friendship Hospital Attached To The Capital Medical University, Beijing, Beijing, China
🇨🇳
The First Affiliated Hospital of Fujian Medical University, FuZhou, Fujian, China

and more 13 locations

ESTD vs. VATS for Upper Gastrointestinal Submucosal Tumors

Not Applicable

Conditions: Gastrointestinal Stromal Tumors (GISTs)
Leiomyoma
Upper Gastrointestinal Submucosal Tumors (SMTs)

Interventions: Procedure: ESTD
Procedure: VATS

First Posted Date: 2013-01-15

Last Posted Date: 2013-01-15

Lead Sponsor: Nanfang Hospital, Southern Medical University

Target Recruit Count: 200

Registration Number: NCT01768104

Locations: 🇨🇳
Nanfang Hospital of Southern Medical University, Guangzhou, Guangdong, China

POEM vs. Pneumatic Dilation for Esophageal Achalasia

Not Applicable

Conditions: Esophageal Achalasia

Interventions: Procedure: POEM
Procedure: Pneumatic dilation

First Posted Date: 2013-01-15

Last Posted Date: 2013-01-15

Lead Sponsor: Nanfang Hospital, Southern Medical University

Target Recruit Count: 200

Registration Number: NCT01768091

Locations: 🇨🇳
Nanfang Hospital of Southern Medical University, Guangzhou, Guangdong, China

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy